Bio-Techne
TECH
288 hedge funds and large institutions have $4.31B invested in Bio-Techne in 2016 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 94 increasing their positions, 100 reducing their positions, and 13 closing their positions.
269% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 13
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
22% more capital invested
Capital invested by funds: $3.53B → $4.31B (+$783M)
12% more funds holding
Funds holding: 257 → 288 (+31)
6% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 100
Top Buyers
Top Sellers
TECH Hedge Fund Activity: Q2 2016 in Review
288 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2016, worth a combined $4.31B — up 22% from $3.53B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new TECH positions and 13 closed out — a net gain of 35 holders — while 94 added to existing stakes and 100 trimmed.
The largest buyer was Macquarie Group, adding an estimated $111M. The largest seller was Janus Henderson Investors US, cutting an estimated $41.8M.
- 288 institutional investors held Bio-Techne (TECH) as of Q2 2016, up from 257 in Q1 2016.
- Funds reported $4.31B of Bio-Techne stock for Q2 2016, up 22% quarter-over-quarter.
- 48 funds opened new Bio-Techne positions in Q2 2016 and 13 closed out, a net change of +35 holders.
- The largest Bio-Techne buyer in Q2 2016 was Macquarie Group, an estimated $111M added.
- The largest Bio-Techne seller in Q2 2016 was Janus Henderson Investors US, an estimated $41.8M sold.
Based on aggregated 13F filings for Q2 2016.